Search
Search Results
-
Response to: regarding the significance of anti-COVID-IgA antibody response in COVID-19 breakthrough infection
In response to Chen et al.’s comments on our paper regarding the significance of anti-COVID-IgA antibody response in COVID-19 breakthrough infection...
-
Significance of Anti-COVID-IgA antibody response in COVID-19 breakthrough infection in vaccinated patients – a single-centered study from Pakistan
An increasing number of breakthrough-COVID-19-vaccinated individuals are being reported across the world. Humoral immunity has a crucial role in...
-
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients
The long-term clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has...
-
The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers
Background/AimsThe aim of this study was to determine the rate of natural and breakthrough infection and related symptoms of Covid-19 amongst Iranian...
-
Characterization of a breakthrough vaccine escape strain associated with overt hepatitis B virus infection
Hepatitis B virus (HBV) vaccine is composed of the purified hepatitis B surface antigen (HBsAg) that is produced by recombinant DNA technology. The...
-
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between individuals, and immune responses correlate with...
-
Long COVID after breakthrough SARS-CoV-2 infection
The post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection—also referred to as Long COVID—have been described,...
-
-
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of vaccinated individuals is increasingly common but rarely results in severe...
-
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infections in vaccinated individuals and reinfections in previously...
-
Nanotechnology: A Recent Breakthrough Against Resistant Biofilm Infection
Microbial biofilms are involved in most medical device-related illnesses, and they continue to be a problem for modern medicine. The multidrug...
-
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in fully vaccinated individuals are receiving intense...
-
Assessment of antibody responses against SARS-CoV-2 in unvaccinated individuals and vaccinees from Omicron-BA.2 infection in Zhaoqing, Guangdong Province, China
Currently, the majority of the global population has been vaccinated with the COVID-19 vaccine, and characterization studies of antibodies in vivo...
-
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization
Background and PurposeWaning immunity and the surge of SARS-CoV-2 variants are responsible for breakthrough infections, i.e., infections in fully...
-
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic
PurposeThe purpose of this study is to investigate the kinetics of response against SARS-CoV-2 elicited by vaccination and/or breakthrough infection...
-
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
BackgroundConsolidated evidence suggests spontaneous immunity from SARS-CoV-2 is not durable, leading to the risk of reinfection, especially in the...
-
SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose
BackgroundOmicron variant (B.1.1.529) is a dominant variant worldwide. However, the risk factors for Omicron variant clearance are yet unknown. The...
-
Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine
Background and objectiveCOVID-19 infection poses a special challenge to patients with dialysis patients. The purpose of this study was to evaluate...
